Neautus Files for Hong Kong Listing, Highlighting Sustained Growth and Strengthening Cash Flow Quality
HONG KONG, May 6, 2026 – (ACN Newswire via SeaPRwire.com) – The traditional Chinese medicine (TCM) decoction pieces sector continues to expand steadily, while its industry structure evolves toward greater standardization and consolidation.Against this backdrop, Sichuan Neautus Traditional Chinese Medicine (Pieces) Co., Ltd. (“Neautus”) has completed its filing with the China Securities Regulatory Commission (CSRC) for overseas issuance and submitted its listing application to the Hong Kong Stock Exchange on April 30, 2026. The development marks a meaningful step in bringing a traditionally fragmented industry closer to capital markets, with increasing investor focus on sustainable growth, operational discipline, and cash flow quality.Scale and Standardization Position Leaders to BenefitDespite its large market size, estimated at around RMB 300 billion, the TCM decoction pieces industry remains relatively fragmented, leaving substantial room for consolidation. As regulatory standards continue …
